{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:16:51Z","timestamp":1788898611417,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011306","name":"American Society for Investigative Pathology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bbrep.2025.102365","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:57:25Z","timestamp":1763665045000},"page":"102365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Epigallocatechin-3-Gallate: A potential amyloid Fibril Disaggregator of Serum amyloid A1"],"prefix":"10.1016","volume":"44","author":[{"given":"Natalie G.","family":"Horgan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anabela","family":"Djurovic-topalovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiwo A.","family":"Ademoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah I.","family":"Reyes-Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsumi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Germ\u00e1n","family":"Plascencia-Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Perry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1007-9360","authenticated-orcid":false,"given":"Jessica S.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.102365_bib1","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4049\/jimmunol.116.5.1415","article-title":"Isolation and partial characterization of SAA-an amyloid-related protein from human serum","volume":"116","author":"Rosenthal","year":"1976","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrep.2025.102365_bib2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrep.2025.102365_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0281822","article-title":"AA-amyloidosis in cats (Felis catus) housed in shelters","volume":"18","author":"Ferri","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.102365_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1432-1327.1999.00657.x","article-title":"Serum amyloid A, the major vertebrate acute-phase reactant","volume":"265","author":"Uhlar","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbrep.2025.102365_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.bbrep.2025.102365_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/01652176.2023.2267605","article-title":"Investigation of serum amyloid a within animal species focusing on the 1-25 amino acid region","volume":"43","author":"Horgan","year":"2023","journal-title":"Vet. Q."},{"key":"10.1016\/j.bbrep.2025.102365_bib7","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.febslet.2009.04.026","article-title":"Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis","volume":"583","author":"Westermark","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2025.102365_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00795-008-0401-3","article-title":"Pathological study on amyloidosis in Cygnus olor (mute swan) and other waterfowl","volume":"41","author":"Tanaka","year":"2008","journal-title":"Med. Mol. Morphol."},{"key":"10.1016\/j.bbrep.2025.102365_bib9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3109\/13506129609014375","article-title":"Amyloid proteins and amyloidosis in domestic animals","volume":"3","author":"Johnson","year":"1996","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrep.2025.102365_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1748-5827.1994.tb03824.x","article-title":"Role of 1\u2013123 serum amyloid Srotein in the etection of familial amyloidosis in Oriental cats","volume":"35","author":"Piirsalu","year":"1994","journal-title":"J. Small Anim. Pract."},{"key":"10.1016\/j.bbrep.2025.102365_bib11","series-title":"Systemic Amyloidosis in Oriental and Siamese Cats","first-page":"66","author":"Zuber","year":"1993"},{"key":"10.1016\/j.bbrep.2025.102365_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/13506129909007328","article-title":"Familial amyloidosis in cats: siamese and Abyssinian AA proteins differ in primary sequence and pattern of deposition","volume":"6","author":"Niewold","year":"1999","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrep.2025.102365_bib13","doi-asserted-by":"crossref","first-page":"16001","DOI":"10.1021\/acs.inorgchem.4c02456","article-title":"eta(6)-Arene Ru(II) complexes as modulators of amyloid aggregation","volume":"63","author":"Florio","year":"2024","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.bbrep.2025.102365_bib14","article-title":"Hydroxytyrosol, tyrosol and derivatives and their potential effects on human health","volume":"24","author":"Markovi\u0107","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.bbrep.2025.102365_bib15","doi-asserted-by":"crossref","first-page":"7710","DOI":"10.1073\/pnas.0910723107","article-title":"EGCG remodels mature alpha-synuclein and amyloid-beta fibrils and reduces cellular toxicity","volume":"107","author":"Bieschke","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2025.102365_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nsmb.1437","article-title":"EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers","volume":"15","author":"Ehrnhoefer","year":"2008","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.bbrep.2025.102365_bib17","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jmb.2012.01.013","article-title":"Structural properties of EGCG-induced, nontoxic Alzheimer's disease Abeta oligomers","volume":"421","author":"Lopez del Amo","year":"2012","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrep.2025.102365_bib18","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/acschemneuro.0c00277","article-title":"Green tea extracts EGCG and EGC display distinct mechanisms in disrupting Abeta(42) protofibril","volume":"11","author":"Zhan","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bbrep.2025.102365_bib19","doi-asserted-by":"crossref","first-page":"21299","DOI":"10.1074\/jbc.M114.554667","article-title":"How epigallocatechin gallate can inhibit alpha-synuclein oligomer toxicity in vitro","volume":"289","author":"Lorenzen","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.102365_bib20","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.1021\/bi100939a","article-title":"The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity","volume":"49","author":"Meng","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrep.2025.102365_bib21","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1016\/j.febslet.2009.10.062","article-title":"Binding of epigallocatechin-3-gallate to transthyretin modulates its amyloidogenicity","volume":"583","author":"Ferreira","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2025.102365_bib22","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.febslet.2011.06.030","article-title":"Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation","volume":"585","author":"Ferreira","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2025.102365_bib23","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/hmg\/ddl210","article-title":"Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models","volume":"15","author":"Ehrnhoefer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbrep.2025.102365_bib24","first-page":"218","article-title":"Epigallocatechin 3-Gallate as an inhibitor of tau phosphorylation and aggregation: a molecular and structural Insight","volume":"4","author":"Gueroux","year":"2017","journal-title":"J Prev Alzheimers Dis"},{"key":"10.1016\/j.bbrep.2025.102365_bib25","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1074\/jbc.M116.750323","article-title":"Aggregation of full-length immunoglobulin light chains from systemic light chain amyloidosis (AL) patients is remodeled by Epigallocatechin-3-gallate","volume":"292","author":"Andrich","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.102365_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jmb.2009.07.031","article-title":"(-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway","volume":"392","author":"Hudson","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrep.2025.102365_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28217262","article-title":"The green tea polyphenol epigallocatechin-gallate (EGCG) interferes with Microcin E492 amyloid Formation","volume":"28","author":"Aguilera","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bbrep.2025.102365_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/13506129.2019.1568978","article-title":"Cell assay for the identification of amyloid inhibitors in systemic AA amyloidosis","volume":"26","author":"Puscalau-Girtu","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.bbrep.2025.102365_bib29","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-022-32951-4","article-title":"Structure-based discovery of small molecules that disaggregate Alzheimer's disease tissue derived tau fibrils in vitro","volume":"13","author":"Seidler","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2025.102365_bib30","doi-asserted-by":"crossref","first-page":"32508","DOI":"10.1039\/C7RA03752J","article-title":"(\u2212)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of \u03b1-synuclein, and protects PC12 cells against \u03b1-synuclein-induced toxicity","volume":"7","author":"Zhao","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.bbrep.2025.102365_bib31","doi-asserted-by":"crossref","first-page":"8155","DOI":"10.1021\/acs.jpcb.2c04230","article-title":"Insights into molecular mechanisms of EGCG and apigenin on disrupting amyloid-beta protofibrils based on molecular dynamics simulations","volume":"126","author":"Fang","year":"2022","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbrep.2025.102365_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2217835120","article-title":"Small molecules disaggregate alpha-synuclein and prevent seeding from patient brain-derived fibrils","volume":"120","author":"Murray","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrep.2025.102365_bib33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11926-024-01147-8","article-title":"A contemporary view","volume":"26","author":"Mirioglu","year":"2024","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.bbrep.2025.102365_bib34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0300985820970490","article-title":"Comparison of AA amyloid fibril morphology and serum amyloid A gene sequence in 5 animal species","volume":"58","author":"Lin","year":"2021","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.bbrep.2025.102365_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI105784","article-title":"The characterization of soluble amyloid prepared in water","volume":"47","author":"Pras","year":"1968","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bbrep.2025.102365_bib36","article-title":"CryoEM reveals how the small molecule EGCG binds to Alzheimer's brain-derived tau fibrils and initiates fibril disaggregation","author":"Seidler Pm","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.bbrep.2025.102365_bib37","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1007\/s11064-016-1995-9","article-title":"Epigallocatechin gallate (EGCG) inhibits Alpha-Synuclein aggregation: a potential agent for Parkinson's Disease","volume":"41","author":"Xu","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbrep.2025.102365_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jff.2011.08.003","article-title":"Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives","volume":"4","author":"Zhong","year":"2012","journal-title":"J. Funct.Foods"},{"key":"10.1016\/j.bbrep.2025.102365_bib39","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/ars.2020.8134","article-title":"Preventive and therapeutic strategies in Alzheimer's Disease: focus on oxidative stress, redox metals, and ferroptosis","volume":"34","author":"Plascencia-Villa","year":"2021","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.bbrep.2025.102365_bib40","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4103\/0972-2327.144284","article-title":"Toxic species in amyloid disorders: oligomers or mature fibrils","volume":"18","author":"Verma","year":"2015","journal-title":"Ann. Indian Acad. Neurol."},{"key":"10.1016\/j.bbrep.2025.102365_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050767","article-title":"Green tea Epigallocatechin-3-gallate (EGCG) targeting protein misfolding in drug discovery for neurodegenerative diseases","volume":"11","author":"Goncalves","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbrep.2025.102365_bib42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.febslet.2014.11.026","article-title":"The green tea polyphenol (-)-epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios","volume":"589","author":"Wobst","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrep.2025.102365_bib43","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1474-4422(19)30141-3","article-title":"Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial","volume":"18","author":"Levin","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbrep.2025.102365_bib44","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00392-012-0463-z","article-title":"Green tea halts progression of cardiac transthyretin amyloidosis: an observational report","volume":"101","author":"Kristen","year":"2012","journal-title":"Clin. Res. Cardiol."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825004522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825004522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T17:43:20Z","timestamp":1766598200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825004522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":44,"alternative-id":["S2405580825004522"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102365","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigallocatechin-3-Gallate: A potential amyloid Fibril Disaggregator of Serum amyloid A1","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102365","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102365"}}